Active Ingredient(s): Meropenem + Vaborbactam
FDA Approved: * August 29, 2017
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Vabomere Overview

Vaborbactam (INN)[1] is a non-β-lactam β-lactamase inhibitor discovered by Rempex Pharmaceuticals, a subsidiary of The Medicines Company. While not effective as an antibiotic by itself, it restores potency to existing antibiotics by inhibiting the β-lactamase enzymes that would otherwise degrade them. When combined with an appropriate antibiotic it can be used for the treatment of gram-negative bacterial infections.[2] In the United States, the c...

Read more Vabomere Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Vabomere Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Meropenem + Vaborbactam
  • Powder: 1gm/vial + 1gm/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Vabomere: (2 results)

Sorted by National Drug Code
  • 65293-009 Vabomere Intravenous Injection, Powder, for Solution by The Medicines Company
  • 70842-120 Vabomere Intravenous Injection, Powder, for Solution by Melinta Therapeutics, Inc.

Drugs with one or more similar ingredients: (3 results)